Dr. Charles J Eldredge, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 555 French Rd, Suite 103, New Hartford, NY 13413 Phone: 315-735-3541 Fax: 315-724-3255 |
Ahmad Mian, Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 555 French Rd, Suite 103, New Hartford, NY 13413 Phone: 315-735-3541 |
Dr. Ira S Tisch, M.D. Internal Medicine - Nephrology Medicare: Not Enrolled in Medicare Practice Location: 555 French Rd, Suite 103, New Hartford, NY 13413 Phone: 315-735-3541 Fax: 315-724-3255 |
Jershang Lin, Internal Medicine - Nephrology Medicare: Not Enrolled in Medicare Practice Location: 58 Janet Ter, New Hartford, NY 13413 Phone: 315-797-6090 |
News Archive
In this post in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, editor Amie Newman, a communications officer at the foundation, notes that in 2007, "Kenya enacted a new constitution which ... declares reproductive health care the right of all citizens," and writes, "Kenya's climb towards broad contraceptive coverage, and with that the hope for increased empowerment for women and girls and an improved economic situation for all, seems steep but scalable."
New brain research is unlocking long-standing mysteries, explaining how the brain trains itself and how human beings develop their superior cognitive skills. New scanning tools (FMRI, SPECT, QEEG, etc.) are advancing neurology's understanding of a process called neuroplasticity and shedding light on a simple looking balance and movement regimen used since 1982 by developmental specialists to treat people with ADHD, Dyslexia and other learning differences.
Vital progress in stem cell research by hundreds of U.S. laboratories is threatened after last week's injunction prohibiting federal funding for the study of human embryonic stem cells (hESCs). The president of the International Society for Stem Cell Research (ISSCR), Elaine Fuchs, Rockefeller University, U.S., stated that the setbacks for advancing biomedical research on stem cells and translating this knowledge into new and improved treatments for patients are already considerable, and escalate with each day the injunction continues.
The protein, Akt3, appears to be responsible for promoting tumor cell survival and development in 43 percent to 60 percent of non-inherited melanomas.
Patients with advanced colorectal cancer may be spared from a toxic side effect caused by a type of targeted therapy used to treat the cancer with the help of another drug normally used to treat melanoma, according to a study led by researchers at the UCLA Jonsson Comprehensive Cancer Center and Memorial Sloan Kettering Cancer Center.
› Verified 7 days ago